ATRA Atara Biotherapeutics Extremely Bullish Reaction To Private Placement – ICPT Case Studyby Olivier on July 13, 2015A few days ago ATRA – Atara Biotherapeutics announced a private placement. The key is how a stock reacts to such news. If your goal is to reach peak performance in trading you pay attention to price and you ignore everything else. The […]
URGENT: Today is the FINAL day to save $1,000 by pre-ordering your copy HERE of ‘Trading Tickers’…only a few spots left for Tim Grittani’s one-time only live trading webinar too…no more extensions, no whining after today, you have 24 hours from the time this blog post is published, go HERE, save a ton of money and get ready to learn […]
Biotech gains attainable?
Mad Money’s Jim Cramer picked up on a biotech pattern that could benefit your portfolio.
Jim Cramer has picked up on a pattern when it comes to biotech stocks that could change the game for an investor’s portfolio—listen to the darned CEO interviews.In fact, Cramer would argue that the biotech group has gone from being hit or miss to […]
Eleven Biotherapeutics (EBIO – Snapshot Report) suffered a huge setback with its lead pipeline candidate failing in a late-stage study. Meanwhile, companies like bluebird (BLUE – Snapshot Report), Agios (AGIO – Snapshot Report) and Acceleron (XLRN – Snapshot Report) all got encouraging news on the regulatory front. Achillion (ACHN – Snapshot Report) struck a collaboration agreement with Johnson & Johnson […]
A new study by Zhi Da, Viola D. Hank Associate Professor of Finance at the University of Notre Dame, shows that the growth rate in industrial electricity usage negatively predicts next one-year stock market returns.“For example, if the industrial electricity usage this month is one percent lower than that in the same month last year, we predict the stock market […]
Study after study of the money managers who have had the best long term performance shows the same thing—-while the money managers made a lot of money over time, the average client lost money. This isn’t some sort of Ponzi scheme, it is because investors and advisers tend to buy into money managers or strategies when they are doing well […]
Something rare is happening in the market
Jonathan Krinsky, MKM Partners, turns a technical eye on the S&P to get a read on “three black crows” and whether the negative trend will continue. And CNBC’s Courtney Reagan and the Futures Now Traders Scott Nations and Jeff Kilburg have a short trade on the S&P’s anomaly.
Stocks erased their early losses, spurring some […]
When you’ve been around the penny stock trading block as long as I have, you get pretty sick and tired of hearing the same lies going around again and again.While I’m long past the point of falling victim to these schemes, what I hate is that they have the potential to discourage my trading challenge students from getting active with […]
If you follow me on Twitter you will have noticed my latest tweet on what to expect during uptrends and downtrends:This is my 17th year trading the markets. The above statement is the essence of what I am experiencing on a daily basis. In order to get exposure to potential super winners you have to identify the right pond to […]
Source: Flickr user epSos .de .There might not be a bell that will ring to alert investors when they have put their money in the wrong biotech stock, but there are warning signals that can help them avoid owning the most dangerous biotech companies. Our Motley Fool contributors explain what these warning signals are and how to use them to […]